Plain-English translation of NCT06611098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tested ABIO3419, a new injectable treatment designed to help people with moderate knee osteoarthritis who had not responded well to oral pain medications. Researchers compared this medication to Synvisc, a well-established knee injection, to see which one worked better and was safer for treating knee pain and function.
Knee osteoarthritis is a common condition that causes pain and stiffness, and many people do not get enough relief from regular pain pills. This trial was designed to evaluate whether the new treatment could offer a better option for people in this situation.
Participants who enrolled were randomly assigned to receive either ABIO3419 or Synvisc as a single injection directly into the knee joint. Throughout the trial, participants attended study visits where researchers checked their pain levels, knee function, and any side effects to compare how well each treatment worked over time.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Georgia
Latvia